Polygenic risk scores (PRSs) have been studied for predicting human diseases, and various methods for PRS calculation have been developed. Most PRS studies to date have focused on European ancestry, and the performance of PRS has not been sufficiently assessed in East Asia. Herein, we evaluated the best-performing PRSs for East Asian populations using data for seven diseases: asthma, breast cancer, coronary artery disease, glaucoma, hyperthyroidism, hypothyroidism, and type 2 diabetes (T2D). A total of 42 PRSs were generated for East Asian samples by applying three PRS methods [linkage disequilibrium (LD) pruning and P-value thresholding (P + T), PRSice, and PRS-CS] and genome-wide association study (GWAS) data from two biobank-scale datasets [European (UK Biobank) and East Asian (BioBank Japan)] to seven diseases. In most cases, PRS-CS showed better predictive performance for disease risk than the other methods and classified low- and high-risk groups more clearly. In addition, the East Asian GWAS data outperformed those from Europeans for T2D PRS, but neither of the two GWAS ancestries showed a dominant effect on PRS performance for other diseases. For East Asian populations, PRS-CS using large-sample GWAS data is likely to provide superior performance, and a PRS generated with GWAS from other ancestries may also perform well.